NEW YORK, NY / ACCESSWIRE / December 10, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: ImmunoGen, Inc. (NASDAQ: IMGN), Ultra Petroleum Corp. (NYSE: UPL), Cardiovascular Systems Inc (NASDAQ: CSII) and Square Inc (NYSE: SQ). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
IMGN Research Package: http://www.traders-choice.com/pdf?s=IMGN
UPL Research Package: http://www.traders-choice.com/pdf?s=UPL
CSII Research Package: http://www.traders-choice.com/pdf?s=CSII
SQ Research Package: http://www.traders-choice.com/pdf?s=SQ
============
Highlights from today's reports include:
On Wednesday, December 09, 2015, Nasdaq Composite ended at 5,022.87, down 1.48%, Dow Jones declined 0.43%, to finish the day at 17,492.30, and the S&P closed at 2,047.62, down 0.77%.
- Immunogen Inc's stock decreased by 3.44% to close Wednesday's session at USD 12.64. The company's shares fluctuated in the range of USD 12.50 and USD 13.04. A total of 1.04 million shares exchanged hands, which was lesser than its 50-day daily average volume of 1.08 million shares and was below its 52-week average volume of 1.65 million shares. Over the last three days Immunogen Inc's shares have declined by 4.53% and in the past one week it has moved down 3.95%. Furthermore, over the last three months, the stock has lost 2.99% while year to date, the stock has gained 107.21%. The stock is at a price to book ratio of 98.07. The historical PB ratio is near to 35.47. Additionally, the stock is trading at a price to sales ratio of 13.06. The Company has a market capitalization of USD 1.10 billion.
- Ultra Petroleum Corp's stock added 2.99% to close Wednesday's session at USD 3.10. The company's shares oscillated between USD 2.91 and USD 3.36. The stock recorded a trading volume of 4.23 million shares, which was above its 50-day daily average volume of 3.22 million shares and above its 52-week average volume of 2.60 million shares. Over the last five days, Ultra Petroleum Corp's shares have declined by 13.65% and in the past one month, it has lost 41.62%. Further, the company is trading at a price to earnings ratio of 2.31 and the stock is at a price to book ratio of 2.15. This compares to a historical PE ratio of 3.75. The historical PB ratio is near to 9.51. Additionally, the stock is trading at a price to cash flow ratio of 0.83 and price to sales ratio of 0.48.
- Cardiovascular Systems Inc's stock declined 3.02% to close Wednesday's session at USD 14.76. The share price vacillated between USD 14.45 and USD 15.21. The stock recorded a trading volume of 0.89 million shares, which was above its 50-day daily average volume of 0.61 million shares and above its 52-week average volume of 0.37 million shares. Over the last three days Cardiovascular Systems Inc's shares have advanced 0.27% and in the past one week it has moved down 4.40%. Moreover, in the last six months, the stock has lost 49.49% and year to date, the shares have shed 50.93%. The stock is at a price to book ratio of 3.78. The historical PB ratio is near to 6.05. Additionally, the stock is trading at a price to sales ratio of 2.69. The Company has a market capitalization of USD 479.69 million.
- Square Inc's stock edged lower by 1.07% to close Wednesday's session at USD 11.99. The company's shares oscillated between USD 11.90 and USD 12.24. The 52-week high of the stock was USD 14.78 while the 52-week low price was USD 9.00. The stock recorded a trading volume of 1.08 million shares, below its 52-week average volume of 6.50 million shares. Over the last three days, Square Inc's shares have declined by 0.42% and in the past one week it has moved up 0.50%. The Company has a market capitalization of USD 323.73 million and the stock is trading at a Price to Sales (ttm) ratio of 1.66. The last traded price of the stock is below its 50-Day Moving Average and 200-Day Moving Average of USD 12.17, each.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
